Thrombus Is Resistant To Fibrinolysis In Patients With Chronic Thromboembolic Pulmonary Hypertension -Possible Involvement Of Thrombin Activated Fibrinolysis Inhibitor (tafi)-

被引：0
|
作者：
Yaoita, N. [1 ]
Fukumoto, Y. [1 ]
Horiuchi, H. [2 ]
Shimokawa, H. [1 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan
[2] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3338
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Thrombin Activated Fibrinolysis Inhibitors (TAFI) Levels in Active Diffuse Systemic Sclerosis Patients
    Ozbalkan, Zeynep
    Apras, Sule
    Pehlevan, Seval Masatlioglu
    Karaaslan, Yasar
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S69 - S69
  • [22] THROMBIN ACTIVATED FIBRINOLYSIS INHIBITORS (TAFI) LEVELS IN ACTIVE DIFFUSE SYSTEMIC SCLEROSIS PATIENTS
    Ozbalkan, Z.
    Apras, S.
    Pehlevan, S. M.
    Sahin, K.
    Yasar, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1020 - 1021
  • [23] LEVEL OF THROMBIN ACTIVATED FIBRINOLYSIS INHIBITOR IN PATIENTS WITH ISCHEMIC STROKE
    Nurillaeva, N. M.
    Zokirova, M. B. Q.
    ATHEROSCLEROSIS, 2021, 331 : E226 - E226
  • [24] Activated TAFI Promotes the Development of Chronic Thromboembolic Pulmonary Hypertension A Possible Novel Therapeutic Target
    Satoh, Taijyu
    Satoh, Kimio
    Yaoita, Nobuhiro
    Kikuchi, Nobuhiro
    Omura, Junichi
    Kurosawa, Ryo
    Numano, Kazuhiko
    Al-Mamun, Elias
    Siddique, Mohammad Abdul Hai
    Sunamura, Shinichiro
    Nogi, Masamichi
    Suzuki, Kota
    Miyata, Satoshi
    Morser, John
    Shimokawa, Hiroaki
    CIRCULATION RESEARCH, 2017, 120 (08) : 1246 - +
  • [25] Coagulation-Fibrinolysis System and Postoperative Outcomes of Patients With Chronic Thromboembolic Pulmonary Hypertension
    Kato, Fumiaki
    Tanabe, Nobuhiro
    Ishida, Keiichi
    Suda, Rika
    Sekine, Ayumi
    Nishimura, Rintaro
    Jujo, Takayuki
    Sugiura, Toshihiko
    Sakao, Seiichiro
    Tatsumi, Koichiro
    CIRCULATION JOURNAL, 2016, 80 (04) : 970 - +
  • [26] Thrombin-activatable fibrinolysis inhibitor (TAFI) is a potential biomarker for cerebral hemorrhage patients
    Wu, Botao
    Wen, Anyan
    Xu, Xuebin
    Zuo, Cheng
    Shan, Baochang
    Li, Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 2121 - 2127
  • [27] Thrombin activatable fibrinolysis inhibitor (TAFI) activity in plasma from patients with diminished endogenous thrombin generation
    Lucia D'Errico, Maria
    de Bosch, Norma
    Ruiz-Saez, Arlette
    Boadas, Apsara
    Ibarra, Carlos
    Maria Salazar, Ana
    Guerrero, Belsy
    INVESTIGACION CLINICA, 2019, 60 (02): : 128 - 140
  • [28] FIBRINOLYSIS IN THE MAJOR VESSEL FORM OF CHRONIC THROMBOEMBOLIC PULMONARY-HYPERTENSION
    LANG, I
    OLMAN, M
    MARSH, J
    JAMIESON, S
    SCHLEEF, R
    MOSER, K
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1133 - 1133
  • [29] Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels in Hypertensive Patients and a Comparison of the Effects of Amlodipine and Ramipril on TAFI Levels
    Ozkan, Gulsum
    Ulusoy, Sukru
    Sonmez, Mehmet
    Karahan, S. Caner
    Mentese, Ahmet
    Kaynar, Kubra
    Bektas, Ozlen
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2013, 35 (02) : 134 - 140
  • [30] Inhibition Of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Demonstrates Therapeutic Efficacy In Bleomycin-Induced Pulmonary Fibrosis In Mice
    Knoerzer, D.
    Baginski, T.
    Wade, K.
    Fan, C.
    Regina, K.
    Rouw, S.
    Palandra, J.
    Rapp, S.
    Burney, M.
    Shih, F.
    Welsch, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
12345